Globus Medical, Inc. Provides Preliminary Sales Guidance for the Fourth Quarter and Full Year Ending December 31, 2019; Provides Sales Guidance for the Year 2020
January 08, 2020 at 04:37 pm EST
Share
Globus Medical, Inc. provided preliminary sales guidance for the fourth quarter and full year ending December 31, 2019. The company anticipates fourth quarter 2019 sales of approximately $211.0 million, an increase of 7.7% over the fourth quarter 2018.
Full year 2019, the company's sales are expected to be approximately $784.7 million, an increase of 10.1% over the prior year.
The company established full year 2020 guidance of $850 million in sales.
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions with a focus on improving the quality of life of patients with musculoskeletal disorders. The Company offers a portfolio of differentiated technologies that are used to treat a variety of musculoskeletal conditions. Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its spine products address the majority of conditions affecting the spine, including degenerative conditions, deformity, tumors, and trauma. It provides solutions that facilitate both open and minimally invasive surgery (MIS) techniques. It includes traditional fusion implants, such as pedicle screws and rod systems. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities, as well as the hip.
Globus Medical, Inc. Provides Preliminary Sales Guidance for the Fourth Quarter and Full Year Ending December 31, 2019; Provides Sales Guidance for the Year 2020
GLOBUS MEDICAL, INC. 
